MMPs, including MT1-MMP, MMP2, and MMP9, are also involved in the CD44-promoted formation of new vasculature and tumour invasion, which can be enhanced by an activation of TGF-β with proteolytically activated MMP-9 [207]. The gene discussed is CD44; the disease is neoplasm.